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Introduction

Pathophysiological Process

Multiple Sclerosis (MS) is an
autoimmune process characterized by
inflammation and demyelination of
axons in the brain and spinal cord
(Schneider, 2005). According to
Maclean (2010), MS is one of the most
common debilitating neurological
disorders in young adults. My intent
of this research project is to explain
the pathophysiological process and
become familiar with the implications
of anesthesia related to MS. This
research will enable me to prepare a
safe, individualized anesthetic plan,
taking all essential precautions when
caring for a patient with multiple
sclerosis.

Underlying pathophysiology:
The etiology of MS is unclear, however there is speculation that the activation of
auto-reactive T lymphocytes occur secondary to the exposure to environmental
factors, an infectious process or viruses ( Ward-Abel, Vernon, & Warner, 2014). After
T lymphocytes are activated, they infiltrate the central nervous system (CNS), by
breaking through the blood brain barrier. T lymphocytes also activate an
inflammatory cascade, which encompasses CD4+ and CD8+ T cells, B cells, interleukin
1, 6, and 11, and tumor necrosis factor, leading to the destruction of
oligodendrocytes and myelin (Gupta et al., 2014). Destruction of oligodendrocytes,
cells that produce myelin, inhibits the body’s ability to remyelinate neurons over time,
leading to scar tissue formation on the neuron and the development of MS lesions
(Schneider, 2005). Demyelination impedes conduction and transmission of nerve
impulses, thus creating cognitive and motor complications throughout the body.
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Symptoms appear and get
worse (progression) from the
start. Relapses are rare. For
those people who have
relapses as well as
progression from the start,
the term ‘progressive
relapsing MS’ is used.

Symptoms appear (relapse)
then resolve, partially or fully
(remission). Relapses last for
at least 24 hours, but
commonly last for weeks or
months. Remissions can last
for weeks or even years. A
relapse is an episode of
neurological disturbance,
caused by inflammation or
demyelination, which occurs
at least 30 days after any
previous episode began, lasts
at least 24 hours and is not
caused by infection or any
other known cause (McDonald
et al 2001).

More than 65% of people who
are initially diagnosed with
relapsing-remitting MS will
enter this phase within
15 years of being diagnosed
(Koch et al 2008). Secondary
progression occurs when
someone has a sustained
progression of MS without
any relapses having taken
place. Some people may
continue
to have relapses.

Symptomology
Symptoms associated with MS are
expressed with varying degrees of
severity and can originate at different
times and locations throughout the
disease process. The variability and
ambiguous nature of the symptoms pose
a challenge to physicians when
attempting to diagnose an individual
with MS. The symptomology of MS can
be categorized as subjective or
objective.
Subjective symptoms:
•
Pain
•
Fatigue
•
Trigeminal Neuralgia
•
Muscles Spasms
•
Weakness
•
Parasthesias
•
Cognitive Deficits
•
Visual Disturbances
•
Mood Instability
•
Sexual Dysfunction
•
Bladder and Bowel Dysfunction
(Maclean, 2010)
Objective Symptoms:
•
Tremors
•
Ataxia
•
Dysarthria
(Maclean, 2010)

Relapsing-remitting

Conclusion

(MacLean, 2010)

Implications for Anesthesia
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Significance of pathophysiology related to anesthesia:
The pathophysiological significance of MS is individualistic. The severity of ones
illness ranges from benign symptoms to a debilitating disease process, which guides
healthcare providers in their plan of treatment. The four conceptions that are
thought to provoke a relapse of MS symptoms are, infection, the post partum period,
high stress environments, and hyperthermia (Ward-Abel et al., 2014). Therefore, it is
paramount that anesthesia providers conduct an extensive review of one’s surgical,
medical and family history in order to create a safe plan for anesthesia. In
combination with a detailed history, the nurse anesthetist (NA) must also conduct a
thorough head to toe assessment. The physical assessment provides insight
regarding physical frailties, such as respiratory, cardiovascular, neurological or bowel
complications that the individual may experience, which further guides the nurse
anesthetist’s plan for anesthesia. Patient education is also vital to the prevention of
MS relapse during the pre and postoperative phases.

According to Schneider (2005), the stress of surgery and use of
anesthetic agents will not lead to an exacerbation of MS symptoms,
yet the complications of surgery, such as infection and hyperthermia
have the potential to trigger a relapse. The anesthesia provider must
consider the individual’s severity of debilitation when devising an
anesthetic plan. If the patient has respiratory weakness secondary to
MS, then the NA would likely elect to place the patient under general
anesthesia, to mechanically ventilate the patient (Schneider, 2005).
Depending on the severity of weakness the patient may be difficult to
extubate immediately after the operation, so a plan should be made
with the intensive care team for postoperative care. Temperature
control is crucial for all MS patients. Demyelinated axons are
sensitive to increases in a patient’s body temperature, further
blocking the conduction of nerve impulses (Schneider, 2005). Studies
show that an increase of 1° C can be significant and exacerbation of
symptoms could ensue (Schneider, 2005). Therefore, the NA should
have a cooling blanket under the patient prior to positioning for
surgery.
Knowing an individual’s degree of illness enables the NA to choose
the appropriate neuromuscular blocking agent. Individuals who
exhibit extreme muscle weakness and atrophy are known to release
excessive potassium from their cells after administration of
succinylcholine, which could be devastating to an individual with MS
who also has heart disease (Schneider, 2005).

Nondepolarizing neuromuscular blocking agents have been proven
to be safe for administration, but the effects can be prolonged or
resistant depending once again, on the individual’s degree of
neuromuscular involvement (Schneider, 2005).
Important considerations when discussing regional anesthesia, often
used during labor and delivery, cesarean sections, and orthopedic
cases is the use of epidural versus spinal approaches to anesthesia.
Studies have shown that the use of spinal anesthesia has led to
exacerbations in MS symptoms along with having a higher risk of
nerve damage (Schneider, 2005). Epidural anesthesia and
peripheral nerve blocks are safe, effective and are the preferred
routes of regional anesthesia, when caring for a patient with MS
(Schneider, 2005).
Lastly, bowel dysfunction is a major problem for some individuals
with MS. It is well known that general anesthesia often creates a
temporary postoperative ileus. Consequently, it is important for the
NA to ensure the patient is on a bowel regimen including
ambulation, stool softeners, and prokinetic medications if needed.

In conclusion, Multiple Sclerosis is an
autoimmune process leading to the
demyelination of axons, which slows the
conduction and transmission of nerve
impulses throughout the body. A wide
array of neuromuscular complications can
occur secondary to neuronal damage.
Nurse anesthetists must create an
anesthetic plan for each MS patient he or
she encounters individually, depending on
the patient’s complications and degree of
disease progression.

It is our duty as healthcare providers to
educate our patients to ensure they
have the information necessary to make
informative decisions, preventing
postoperative complications and
decreasing the risk for exacerbation of
symptoms related to MS.
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